Showing results (81-90 of 284) with videos related to
Sort By:
Pageof 29
ACS Medicinal Chemistry Letters|November 19, 2025
Novel 2H‑Pyrazolo[3,4‑d]thiazole Compounds Targeting NLRP3 for the Treatment of Neurodegenerative DiseasesZhendong Song, Steven H LiangACS Medicinal Chemistry Letters|January 14, 2026
Novel Substituted Spiro-Ureas as Monoacylglycerol Lipase InhibitorsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|February 18, 2026
Novel Substituted Benzisoxazole Sulfonamides as Lysine Acetyl Transferase Inhibitors for the Treatment of CancersJian Rong, Steven H LiangAmerican Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Novel tracers and emerging targets for positron emission tomography in Alzheimer's disease and related dementiasTaoqian Zhao, Steven H LiangACS Medicinal Chemistry Letters|September 17, 2025
Development of Bicyclic Compounds Containing a Tertiary Amine Moiety as T Cell ActivatorsTaoqian Zhao, Steven H LiangACS Medicinal Chemistry Letters|September 17, 2025
Novel Indazole Propionic Acid Derivatives as AMPK ActivatorsJian Rong, Steven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Novel Isoindolin-1-one Derivatives as Metabotropic Glutamate Receptor Positive Allosteric ModulatorsYinlong Li, Steven H LiangACS Medicinal Chemistry Letters|July 16, 2025
Targeted Treatment of Cancer by Using Conjugate Compounds with Poly(ADP-ribose) Polymerase (PARP) InhibitorsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|February 19, 2025
Novel Heterocyclic Piperazine Amide Derivatives as Alpha-synuclein PET Ligands for Diagnosis of Parkinson's DiseaseYinlong Li, Steven H LiangACS Medicinal Chemistry Letters|May 20, 2026
Novel Substituted Tetrahydropyrrolooxazolones as RIPK1 InhibitorsJian Rong, Steven H LiangPageof 29